Correlation between baseline CD4+ T-lymphocyte count and plasma viral load in AIDS patients and their early clinical and immunological response to HAART: A preliminary study

Indian Journal of Medical Microbiology

Volumn 26, Issue 3, 2008, Pages 256-258

  Gautam, H ^a   Bhalla, P ^a   Saini, S ^a   Dewan, R ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

CD4+ T lymphocytes; HAART; Plasma viral load

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COUGHING; DIARRHEA; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS LOAD; WEIGHT REDUCTION;

EID: 48249105145     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.42039     Document Type: Article

References (13)

1. National guidelines for implementation of Anti-Retroviral Therapy (ART). August, 2004. National AIDS Control Organization. [updated on 2007 Jul 31]. Available from: http://www.nacoonline.org/guidelines/ART_Guidelines.pdf.
2. Shahapur PR, Bairy I, Shivananda PG. Effect of "HAART" on CD4+ T lymphocyte counts in HIV seropositive south-Indian individuals: A follow up study. Indian J Pathol Microbiol 2005;48:270-2.
3. Kumarasamy N, Solomon S, Peters E, Amalraj RE, Purnima M, Ravikumar B, et al. Antiretroviral drugs in the treatment of people living with human deficiency virus: Experience in south Indian tertiary referral centre. J Assoc Physic India 2000;48:390-3.
4. Anti-Retroviral Therapy for HIV infection in adults and adolescents in resource-limited settings: Towards universal access. World Health Organization. 2006 revision. [updated on 2007 Jul 31]. Available from: http://www.who.int/hiv/ pub/guidelines/WHO%20Adult%20ART%20Guidelines.pdf.
5. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.
6. Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, et al. Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the International AIDS society-USA panel. JAMA 2002;288:222-35.
7. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. October 10, 2006. Developed by the DHHS panel. [updated on 2007 Jul 31]. Available at: http://aidsinfo.nih.gov/contentfiles/ AdultandAdolescentGL.pdf.
8. Mahajan AP, Hogan JW, Snyder B, Kumarasamy N, Mehta K, Soloman S, et al. Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: Implications for monitoring in resource-limited settings. J Acquir Immune Defic Syndr 2004;36:567-75.
9. Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, et al. Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in Southern India. J Acquir Immune Defic Syndr 2006;41:53-8.
10. Ray K, Gupta SM, Bala M, Muralidhar S, Kumar J. CD4/CD8 lymhocyte counts in healthy, HIV positive individuals and AIDS patients. Indian J Med Res 2006;124:319-30.
11. Pirzada Y, Khuder S, Donabedian H. Predicting AIDS-related events using CD4 percentage or CD4 absolute counts. AIDS Res Ther 2006;3:20.
12. Liotta G, Perno CF, Ceffa S, Gialloreti LE, Coehlo E, Erba F, et al. Is total lymphocyte count a reliable predictor of the CD4 lymphocyte cell count in resource limited settings? AIDS 2004;18:1082-3.
13. Stebbing J, Sawleshwarkar S, Michailidis C, Jones R, Bower M, Mandalia S, et al. Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people. Postgrad Med J 2005;81:586-8.